Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Paracetamol Hepatotoxicity After Therapeutic Doses: Susceptibility Factors and Early Detection Biomarkers

NCT03602274 is registered in ClinicalTrials.gov with University Hospital, Geneva as lead sponsor.

NCT NCT03602274
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03602274 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Paracetamol Hepatotoxicity After Therapeutic Doses: Susceptibility Factors and Early Detection Biomarkers
Lead sponsor
University Hospital, Geneva
Phase
Observational
Overall status
Unknown status
Start date
February 10, 2015
Completion date
December 31, 2018
Enrollment
96 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatotoxicity, malnutrition, paracetamol toxicity